Repligen Corporation beat EPS estimates 81% of the time across 16 reported quarters (13 beats, 3 misses), averaging +13.1% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $0.45 | $0.54 | +20.0% | Beat | |
| Q1 FY26 | $0.38 | $0.48 | +26.3% | Beat | Q1 FY26 call · transcript |
| Q4 FY25 | $0.44 | $0.49 | +11.4% | Beat | Q4 FY25 call · transcript |
| Q3 FY25 | $0.42 | $0.46 | +9.5% | Beat | |
| Q2 FY25 | $0.40 | $0.37 | -7.5% | Miss | Q2 FY25 call · transcript |
| Q1 FY25 | $0.35 | $0.39 | +11.4% | Beat | |
| Q4 FY24 | $0.41 | $0.44 | +7.3% | Beat | |
| Q3 FY24 | $0.34 | $0.43 | +26.5% | Beat | |
| Q2 FY24 | $0.33 | $0.33 | +0.0% | Beat | |
| Q1 FY24 | $0.29 | $0.28 | -3.5% | Miss | |
| Q4 FY23 | $0.34 | $0.33 | -2.9% | Miss | |
| Q3 FY23 | $0.14 | $0.23 | +64.3% | Beat |
Back to RGEN overview · RGEN holders · RGEN KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.